PALISADE BIO, INC. (PALI)
Biological Products, (No Diagnostic Substances)
Latest Price
$2.02
TTM P/E
3.10
Normalized P/E
--
Div Yield
--
Book Value
0.58
P/B Ratio
3.48
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | 13.06M | $27.0M | 7.53% | -- | 2026-06-30 |
| B Group, Inc. | 11.41M | $23.0M | 6.58% | -- | 2026-06-30 |
| AMERIPRISE FINANCIAL INC | 11.08M | $23.0M | 6.38% | +2.37M | 2026-06-30 |
| Jupiter Topco LLC | 10.69M | $22.0M | 6.16% | -- | 2026-06-30 |
| BlackRock, Inc. | 10.44M | $21.0M | 6.01% | +8.56M | 2026-06-30 |
| Octagon Capital Advisors LP | 10.28M | $21.0M | 5.92% | -- | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 8.43M | $17.0M | 4.85% | -503.1K | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 7.12M | $14.0M | 4.10% | -- | 2026-06-30 |
| FRANKLIN RESOURCES INC | 5.79M | $12.0M | 3.33% | -- | 2026-06-30 |
| Point72 Asset Management, L.P. | 5.25M | $10.0M | 3.03% | +4.84M | 2026-06-30 |